Literature DB >> 6776415

Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdown.

P K Moore, J R Hoult.   

Abstract

Anti-inflammatory steroids reduce prostaglandin (PG) synthesis in intact cells and isolated organs by interfering indirectly with the phospholipase(s) which release the poly-unsaturated fatty acid precursors for both cyclooxygenase and lipoxygenase pathways. This action requires nucleic acid transcription and synthesis of new protein, and a soluble factor capable of inhibiting PG generation has been identified. However, it is not known whether these steroids affect either the actions or content of the enzymes of the PG system after administration in vivo, nor is it known if they affect PG-metabolizing enzymes. We show here that treatment of rats with anti-inflammatory steroids causes rapid changes in tissue activities of enzymes which synthesize and inactivate PGs, with apparent levels reduced and increased respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776415     DOI: 10.1038/288269a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

1.  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review.

Authors:  S Sauerland; M Nagelschmidt; P Mallmann; E A Neugebauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

2.  Inhibitors of protein and RNA synthesis cause a rapid block in prostaglandin production at the prostaglandin synthase step.

Authors:  J M Fagan; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Intraventricular injections of drugs which inhibit phospholipase A2 suppress fever in rabbits.

Authors:  W I Cranston; R F Hellon; D Mitchell; Y Townsend
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

4.  Monoclonal antibodies that inhibit the enzyme activity of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.

Authors:  C L Tai; O T Mak; T Arai; H H Tai
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase.

Authors:  M Goppelt-Struebe; D Wolter; K Resch
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

6.  The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation.

Authors:  A Kobza Black; M W Greaves; C N Hensby
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  Characterization and partial purification of 'renocortins': two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids.

Authors:  J F Cloix; O Colard; B Rothhut; F Russo-Marie
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester.

Authors:  C Q Xun; Z G Tian; H H Tai
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

9.  Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat.

Authors:  G J Blackwell; R Carnuccio; M Di Rosa; R J Flower; C S Langham; L Parente; P Persico; N C Russel-Smith; D Stone
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

10.  Dexamethasone pre-treatment is antipyretic toward polyinosinic: polycytidylic acid, lipopolysaccharide and interleukin 1/endogenous pyrogen.

Authors:  H Abul; J Davidson; A S Milton; D Rotondo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.